Why Cepheid Is Skyrocketing Today
Shares jump on the news that the company is being bought out by Danaher.
Cepheid
CPHD
CPHD
A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.
News & Analysis: Cepheid
Cepheid's Stock Falls Hard On Preliminary Third Quarter Results
Cepheid's shares erase more than two years of gains after the company released its preliminary third quarter earnings report. Here's why.
3 Stocks to Watch in Medical Diagnostics
There's super-cool science at work here, as well as multiple opportunities for investors.
Why Shares of Cepheid Dropped Today
Molecular diagnostic test company Cepheid stock dropped 12% today after reporting earnings last night. Is the move justified, or just market noise?
Why Cepheid Stock Nosedived
Molecular diagnostic company Cepheid may need to do some internal analyzing after its full-year outlook failed to excite investors.
Why Cepheid Shares Are Climbing
Is this meaningful or just another movement?
Biotech Stocks: Get Your Huge Potential Here
It's win-win when these companies treat diseases and make a lot of money.
Why Cepheid Shares Popped
Is this meaningful or just another movement?
Why Cepheid Shares Dropped
Is this meaningful or just another movement?
Top 10 Cash Offender Countdown: No. 10 to No. 7
Sooner or later, operating cash flow that's all from adding back stock-based comp is unsustainable. Right now, there are 10 really bad offenders -- don't go near them.
